JP2022516710A5 - - Google Patents
Info
- Publication number
- JP2022516710A5 JP2022516710A5 JP2021537208A JP2021537208A JP2022516710A5 JP 2022516710 A5 JP2022516710 A5 JP 2022516710A5 JP 2021537208 A JP2021537208 A JP 2021537208A JP 2021537208 A JP2021537208 A JP 2021537208A JP 2022516710 A5 JP2022516710 A5 JP 2022516710A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- antigen
- protein
- pharmaceutical composition
- hla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788894P | 2019-01-06 | 2019-01-06 | |
| US62/788,894 | 2019-01-06 | ||
| PCT/US2020/012417 WO2020142780A1 (en) | 2019-01-06 | 2020-01-06 | Car t cell methods and constructs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022516710A JP2022516710A (ja) | 2022-03-02 |
| JP2022516710A5 true JP2022516710A5 (enExample) | 2023-01-19 |
Family
ID=71406633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537208A Pending JP2022516710A (ja) | 2019-01-06 | 2020-01-06 | Ｃａｒ ｔ細胞の方法及び構築物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220090132A1 (enExample) |
| EP (1) | EP3906311A4 (enExample) |
| JP (1) | JP2022516710A (enExample) |
| KR (1) | KR20210137427A (enExample) |
| CN (1) | CN113382741A (enExample) |
| AU (1) | AU2020205000A1 (enExample) |
| BR (1) | BR112021013180A2 (enExample) |
| CA (1) | CA3125201A1 (enExample) |
| IL (1) | IL284461A (enExample) |
| PH (1) | PH12021551619A1 (enExample) |
| SG (1) | SG11202107246TA (enExample) |
| WO (1) | WO2020142780A1 (enExample) |
| ZA (1) | ZA202103899B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12419913B2 (en) | 2019-02-08 | 2025-09-23 | Dna Twopointo, Inc. | Modification of CAR-T cells |
| WO2025084880A1 (ko) * | 2023-10-20 | 2025-04-24 | 주식회사 이온셀 | Ct83 항원에 결합하는 car-t 세포 및 이의 용도 |
| CN117567650B (zh) * | 2024-01-15 | 2024-04-02 | 中国人民解放军东部战区总医院 | 共表达细胞间黏附分子icam2的car-t细胞及其制备方法与应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0951544A2 (en) * | 1996-07-03 | 1999-10-27 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of human disease |
| CA2371216A1 (en) * | 1999-04-23 | 2000-11-02 | Centre For Translational Research In Cancer | Pseudotyped retroviral vector for gene therapy of cancer |
| US20060057553A1 (en) * | 2000-05-30 | 2006-03-16 | Estuardo Aguilar-Cordova | Chimeric viral vectors for gene therapy |
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| GB201322798D0 (en) * | 2013-12-20 | 2014-02-05 | Oxford Biomedica Ltd | Production system |
| JP6894236B2 (ja) * | 2014-03-26 | 2021-06-30 | デノボ バイオファーマ エルエルシー | 免疫刺激活性を有するレトロウイルスベクター |
| WO2016160618A2 (en) * | 2015-03-27 | 2016-10-06 | University Of Southern California | Car t-cell therapy directed to lhr for the treatment of solid tumors |
| US10786549B2 (en) * | 2015-04-23 | 2020-09-29 | Baylor College Of Medicine | CD5 chimeric antigen receptor for adoptive T cell therapy |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| MA46236A (fr) * | 2016-09-14 | 2019-07-24 | Janssen Biotech Inc | Récepteurs antigéniques chimériques comprenant des domaines de la fibronectine de type iii spécifiques du bcma, et utilisations correspondantes |
| US12178830B2 (en) * | 2017-06-30 | 2024-12-31 | Memorial Sloan Kettering Cancer Center | Compositions and methods for adoptive cell therapy for cancer |
-
2020
- 2020-01-06 WO PCT/US2020/012417 patent/WO2020142780A1/en not_active Ceased
- 2020-01-06 KR KR1020217020488A patent/KR20210137427A/ko not_active Ceased
- 2020-01-06 AU AU2020205000A patent/AU2020205000A1/en not_active Abandoned
- 2020-01-06 JP JP2021537208A patent/JP2022516710A/ja active Pending
- 2020-01-06 BR BR112021013180A patent/BR112021013180A2/pt not_active IP Right Cessation
- 2020-01-06 SG SG11202107246TA patent/SG11202107246TA/en unknown
- 2020-01-06 US US17/419,239 patent/US20220090132A1/en not_active Abandoned
- 2020-01-06 PH PH1/2021/551619A patent/PH12021551619A1/en unknown
- 2020-01-06 EP EP20736060.3A patent/EP3906311A4/en active Pending
- 2020-01-06 CA CA3125201A patent/CA3125201A1/en active Pending
- 2020-01-06 CN CN202080007932.2A patent/CN113382741A/zh active Pending
-
2021
- 2021-06-07 ZA ZA2021/03899A patent/ZA202103899B/en unknown
- 2021-06-29 IL IL284461A patent/IL284461A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518049A5 (enExample) | ||
| JP2025037871A5 (enExample) | ||
| JP2021500861A5 (enExample) | ||
| JP2021525509A5 (enExample) | ||
| JP2024518011A5 (enExample) | ||
| DK3012268T3 (en) | Chimeric antigen receptors with an optimized hinge region | |
| RU2018122106A (ru) | Буферы для стабилизации лентивирусных препаратов | |
| JP2023525720A5 (enExample) | ||
| FI3380620T3 (fi) | Optimoituja lentiviruksen siirtovektoreita ja niiden käyttötapoja | |
| JP2020500530A5 (enExample) | ||
| IL273948B2 (en) | Compositions and methods for selective protein degradation | |
| JP2024519335A5 (enExample) | ||
| JP2024510900A5 (enExample) | ||
| JP2020517263A5 (enExample) | ||
| US20230028399A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| JP2022516710A5 (enExample) | ||
| IL297514A (en) | Vectors and methods for in vivo transduction | |
| JP2022545167A5 (enExample) | ||
| JP2023500574A5 (enExample) | ||
| IL297547A (en) | Therapeutic interventional particles for the corona virus | |
| JP2021532742A5 (enExample) | ||
| CN110511912A (zh) | 免疫细胞的功能调节 | |
| WO2023288185A2 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| WO2023133540A1 (en) | Il-12 affinity variants | |
| CN111875708A (zh) | 一种嵌合抗原受体t淋巴细胞及其在制备治疗实体肿瘤的产品中的应用 |